PlainRecalls
FDA Drug Moderate Class II Terminated

CycloSPORINE Capsules, USP, 100 mg, 30 count bottle, Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, Manufactured for Apotex Corp., Weston, FL --- NDC 60505-0134-0

Reported: March 1, 2017 Initiated: February 3, 2017 #D-0475-2017

Product Description

CycloSPORINE Capsules, USP, 100 mg, 30 count bottle, Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, Manufactured for Apotex Corp., Weston, FL --- NDC 60505-0134-0

Reason for Recall

Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities.

Details

Recalling Firm
Apotex Inc.
Units Affected
19,584 bottles
Distribution
Distributed Nationwide
Location
North York, N/A

Frequently Asked Questions

What product was recalled?
CycloSPORINE Capsules, USP, 100 mg, 30 count bottle, Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, Manufactured for Apotex Corp., Weston, FL --- NDC 60505-0134-0. Recalled by Apotex Inc.. Units affected: 19,584 bottles.
Why was this product recalled?
Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 1, 2017. Severity: Moderate. Recall number: D-0475-2017.